| The probe left the Mexico City office without a full-time resident director for more than six months in 2021 as Mexico consolidated its role as the No. 1 source of the synthetic opioid in the United States. Upheaval in one of the agency's most important offices was an embarrassing distraction as agents tried to work with Mexico's corruption-ridden security agencies to deter drug trafficking, U.S. officials said. Agency veteran Nick Palmeri, who was investigated for alleged misuse of funds and improper contacts with defense attorneys for narcotraffickers, denied wrongdoing. | 
No comments:
Post a Comment